ecancermedicalscience

Submit article

https://doi.org/10.3332/ecancer.2015.499

Abstract | Full Article |

Case Report

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma

8 Jan 2015

Shripad Banavali, Eddy Pasquier, Nicolas André

We report here a case of a 69-year-old woman with a relapsing metastatic angiosarcoma treated with a combination of metronomic chemotherapy and propranolol. The beta blockers were added since the tumour was positive for betaadrenergic receptor. A complete response was quickly obtained and lasted for 20 months.

With this case, the combination of metronomic chemotherapy and propranolol in angiosarcoma warrants additional studies and illustrates the potential of metronomics to generate innovative yet inexpensive targeted therapies for both high-income and low-/middle-income countries.

Article metrics: 6574 views

2384

4190

2150-safety-of-immune-checkpoint-inhibitors-in-a-diverse-patient-population-a-single-institution-experience

Short Communication: Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience

Grace M Ferri*, John F Murphy*, Akash Oza*, Alexander J B Bulteel, Wafaa Abbasi, Rachel Anderson, Mehmed Taha Dinc, Eva Gaufberg, Kayra Cengiz, Sainikhil Sontha, Janice Weinberg, Patrick Kurpaska, Yashvin Onkarappa Mangala, Matthew Kulke, Umit Tapan

18 Jun 2026

https://doi.org/10.3332/ecancer.2026.2150

Abstract | Full Article | PDF

2149-bringing-leaders-together-to-support-the-development-of-childrens-palliative-care-across-the-asia-pacific-region-an-interdisciplinary-workshop

Conference Report: Bringing leaders together to support the development of children’s palliative care across the Asia Pacific region—an interdisciplinary workshop

Gemma E Aburn, Rima Saad Rassam, Ximena Garcia-Quintero, Marta Salek, Andrea Cuviello, Yadurshini Raveendran, Sri Andini Handayani, Chen Chen Sun, Su Yadana, Sally Blair, Megan Doherty, Min Sun Kim, Zhou Xuan, Marianne B Phillips, Lee Ai Chong, Gayatri Palat, Donna Drew, Justin N Baker, Poh Heng Chong, Julia Downing, Michael J McNeil

17 Jun 2026

https://doi.org/10.3332/ecancer.2026.2149

Abstract | Full Article | PDF

2147-benchmarking-of-radiobiological-ntcp-models-in-head-and-neck-radiotherapy-using-independent-computational-pipelines-an-institutional-validation-study-with-machine-learning-augmentation

Research: Benchmarking of radiobiological NTCP models in head and neck radiotherapy using independent computational pipelines: an institutional validation study with machine learning augmentation

Kalyan Mondal, Abhijit Mandal, Anuj Vijay1c, Ganeshkumar Patel

16 Jun 2026

https://doi.org/10.3332/ecancer.2026.2147

Abstract | Full Article | PDF

2144-use-of-low-dose-immune-checkpoint-inhibitors-in-low-and-middle-income-countries-a-national-survey-of-oncologists-and-hematologists-in-mexico

Research: Use of low-dose immune checkpoint inhibitors in low- and middle-income countries: a national survey of oncologists and hematologists in Mexico

Andres Meraz-Brenez, Enrique Soto-Perez-De-Celis, Roberta Demichelis-Gomez, Leonardo Verduzco-Rodriguez, Arjun Gupta, Meera Ragavan, Fumiko Chino, Haydee Cristina Verduzco-Aguirre

10 Jun 2026

https://doi.org/10.3332/ecancer.2026.2144

Abstract | Full Article | PDF